Nebulizer Systems Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$4000
Buy Report Download FREE Resources

Published: July 22, 2024 Report Code: GDME1789EPD-ST

Select Item

Nebulizer Systems Pipeline Market Report Overview

A nebulizer helps direct medicine delivery in case of respiratory disorders. The nebulizer systems pipeline market research report provides a comprehensive understanding of the pipeline products and their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Territories ·       The United States

·       Australia

·       China

·       Europe

·       New Zealand
Key Regulatory Paths ·       510(k)

·       NMPA

·       TGA

·       CE

·       HSA
Leading Companies ·       Ablynx NV

·       Acu-Flow Ltd

·       Aeon Research & Technology

·       AFT Pharmaceuticals Ltd

·       Bridgesource Medical Corp
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Buy the Full Report for More Insights into the Nebulizer Systems Pipeline Market

Download a Free Report Sample

Nebulizer Systems Pipeline Market Segmentation by Territories

The United States, Australia, China, Europe, and New Zealand among others are the key territories of the nebulizer systems pipeline market. As of July 2024, the US accounts for the highest number of products in the development pipeline.

Nebulizer Systems Pipeline Market Analysis by Territories, 2024 (%)

Nebulizer Systems Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Nebulizer Systems Pipeline Market

Download a Free Report Sample

Nebulizer Systems Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths in the nebulizer systems pipeline products market are 510(k), NMPA, TGA, CE, and HAS among others. As of July 2024, 510(k) is the most followed pathway for pipeline products in the nebulizer systems market.

Nebulizer Systems Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Nebulizer Systems Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Nebulizer Systems Pipeline Market

Download a Free Report Sample

Nebulizer Systems Pipeline Market – Competitive Landscape

A few of the key companies associated with the nebulizer systems pipeline market are Ahblynx NV, Acu-Flow Ltd, Aeon Research & Technology, AFT Pharmaceuticals Ltd, and Bridgesource Medical Corp, among others.

Aeon Research & Technology Company: Aeon Research & Technology (ART) is a medical device manufacturing company that designs, manufactures, develops, and markets medical implants and instruments. It is headquartered in Loves Park, Illinois, the US.

AFT Pharmaceuticals Ltd: AFT Pharmaceuticals Ltd (AFT) develops, markets, and distributes a wide range of medical products. The company’s product portfolio includes both proprietary and in-licensed products and comprises patented, branded, and generic drugs.

Nebulizer Systems Pipeline Market Analysis by Companies, 2024
Nebulizer Systems Pipeline Market Analysis by Companies, 2024Buy the Full Report for More Company Insights into the Nebulizer Systems Pipeline Market
Download a Free Report Sample

Segments Covered in the Report

Nebulizer Systems Pipeline Market Territories Outlook (2024)

  • The United States
  • Australia
  • China
  • Europe
  • New Zealand

Nebulizer Systems Pipeline Market Regulatory Paths Outlook (2024)

  • 510(k)
  • NMPA
  • TGA
  • CE
  • HSA

Scope

This report provides:

  • Extensive coverage of the nebulizer systems under development.

  • Exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.

  • Reviews of major players involved in the development of nebulizer systems and lists all their pipeline projects.

  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.

  • Key clinical trial data of ongoing clinical trials specific to pipeline products.

  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.

  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.

  • Identify and understand important and diverse types of nebulizer systems under development.

  • Develop market-entry and market-expansion strategies.

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.

  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Ablynx NV
Acu-Flow Ltd
Aeon Research & Technology
AFT Pharmaceuticals Ltd
Bridgesource Medical Corp
Caddo Medical Technologies LLC
Clyra Medical Technologies Inc
Creare LLC
DesignWise Medical Inc (Inactive)
HCmed Innovations Co Ltd
LTT Bio-Pharma Co Ltd
Marquette University
Misti Pty Ltd
Monash University
New Air, Inc.
Nob Hill Therapeutics Inc
PARI GmbH
Parion Sciences Inc
Pharmosa Biopharm Inc
Qnovia Inc
RMIT University
Stirling Pharma Inc
Suzhou Wulian Medical Technology Co Ltd
Teleflex Inc
Tianchen (Tianjin) Biotechnology Co Ltd
University of California San Diego
University of Texas Medical Branch at Galveston
Vectura Group Plc
Verona Pharma Plc
Vincent Medical Holdings Ltd
Wellfully Ltd
Wellinks Inc

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 5

|1.2 List of Figures 8

2 Introduction 9

2.1 Nebulizer Systems Overview 9

3 Products under Development 10

3.1 Nebulizer Systems – Pipeline Products by Stage of Development 10

3.2 Nebulizer Systems – Pipeline Products by Territory 11

3.3 Nebulizer Systems – Pipeline Products by Regulatory Path 12

3.4 Nebulizer Systems – Pipeline Products by Estimated Approval Date 13

3.5 Nebulizer Systems – Ongoing Clinical Trials 14

4 Nebulizer Systems – Pipeline Products under Development by Companies 15

4.1 Nebulizer Systems Companies – Pipeline Products by Stage of Development 15

4.2 Nebulizer Systems – Pipeline Products by Stage of Development 17

5 Nebulizer Systems Companies and Product Overview 18

5.1 Ablynx NV Company Overview 18

5.1.1 Ablynx NV Pipeline Products & Ongoing Clinical Trials Overview 18

5.2 Acu-Flow Ltd Company Overview 19

5.2.1 Acu-Flow Ltd Pipeline Products & Ongoing Clinical Trials Overview 19

5.3 Aeon Research & Technology Company Overview 20

5.3.1 Aeon Research & Technology Pipeline Products & Ongoing Clinical Trials Overview 20

5.4 AFT Pharmaceuticals Ltd Company Overview 21

5.4.1 AFT Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview 21

5.5 Bridgesource Medical Corp Company Overview 24

5.5.1 Bridgesource Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 24

5.6 Caddo Medical Technologies LLC Company Overview 25

5.6.1 Caddo Medical Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 25

5.7 Clyra Medical Technologies Inc Company Overview 26

5.7.1 Clyra Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 26

5.8 Creare LLC Company Overview 27

5.8.1 Creare LLC Pipeline Products & Ongoing Clinical Trials Overview 27

5.9 DesignWise Medical Inc (Inactive) Company Overview 28

5.9.1 DesignWise Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 28

5.10 HCmed Innovations Co Ltd Company Overview 29

5.10.1 HCmed Innovations Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 29

5.11 LTT Bio-Pharma Co Ltd Company Overview 30

5.11.1 LTT Bio-Pharma Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 30

5.12 Marquette University Company Overview 31

5.12.1 Marquette University Pipeline Products & Ongoing Clinical Trials Overview 31

5.13 Misti Pty Ltd Company Overview 32

5.13.1 Misti Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 32

5.14 Monash University Company Overview 33

5.14.1 Monash University Pipeline Products & Ongoing Clinical Trials Overview 33

5.15 New Air, Inc. Company Overview 35

5.15.1 New Air, Inc. Pipeline Products & Ongoing Clinical Trials Overview 35

5.16 Nob Hill Therapeutics Inc Company Overview 36

5.16.1 Nob Hill Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 36

5.17 PARI GmbH Company Overview 37

5.17.1 PARI GmbH Pipeline Products & Ongoing Clinical Trials Overview 37

5.18 Parion Sciences Inc Company Overview 38

5.18.1 Parion Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 38

5.19 Pharmosa Biopharm Inc Company Overview 39

5.19.1 Pharmosa Biopharm Inc Pipeline Products & Ongoing Clinical Trials Overview 39

5.20 Qnovia Inc Company Overview 43

5.20.1 Qnovia Inc Pipeline Products & Ongoing Clinical Trials Overview 43

5.21 RMIT University Company Overview 44

5.21.1 RMIT University Pipeline Products & Ongoing Clinical Trials Overview 44

5.22 Stirling Pharma Inc Company Overview 46

5.22.1 Stirling Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview 46

5.23 Suzhou Wulian Medical Technology Co Ltd Company Overview 47

5.23.1 Suzhou Wulian Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 47

5.24 Teleflex Inc Company Overview 48

5.24.1 Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview 48

5.25 Tianchen (Tianjin) Biotechnology Co Ltd Company Overview 49

5.25.1 Tianchen (Tianjin) Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 49

5.26 University of California San Diego Company Overview 50

5.26.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 50

5.27 University of Texas Medical Branch at Galveston Company Overview 51

5.27.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 51

5.28 Vectura Group Plc Company Overview 52

5.28.1 Vectura Group Plc Pipeline Products & Ongoing Clinical Trials Overview 52

5.29 Verona Pharma Plc Company Overview 56

5.29.1 Verona Pharma Plc Pipeline Products & Ongoing Clinical Trials Overview 56

5.30 Vincent Medical Holdings Ltd Company Overview 58

5.30.1 Vincent Medical Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview 58

5.31 Wellfully Ltd Company Overview 59

5.31.1 Wellfully Ltd Pipeline Products & Ongoing Clinical Trials Overview 59

5.32 Wellinks Inc Company Overview 60

5.32.1 Wellinks Inc Pipeline Products & Ongoing Clinical Trials Overview 60

6 Nebulizer Systems- Recent Developments 63

6.1 Jun 18, 2024: Cannabix Technologies Announces Annual General and Special Meeting Results 63

6.2 May 23, 2024: Medline introduces high-efficiency medication delivery system to respiratory portfolio 63

6.3 Apr 09, 2024: Qnovia Announces the Appointment of Four New Members to its Scientific Advisory Board 64

6.4 Mar 27, 2024: Cannabix Technologies Announces Resignation of Kulwant Malhi 65

6.5 Dec 14, 2023: Dongguan Simzo Electronic Technology Receives FDA 510(k) Clearance for SIMZO Ultrasonic Nebulizer 65

6.6 Aug 22, 2023: PARI Respiratory Equipment Receives Additional 510(k) clearance for eRapid Nebulizer System 66

7 Appendix 67

7.1 Methodology 67

7.2 About GlobalData 70

7.3 Contact Us 70

7.4 Disclaimer 70

Table

Nebulizer Systems – Pipeline Products by Stage of Development 10

Nebulizer Systems – Pipeline Products by Territory 11

Nebulizer Systems – Pipeline Products by Regulatory Path 12

Nebulizer Systems – Pipeline Products by Estimated Approval Date 13

Nebulizer Systems – Ongoing Clinical Trials 14

Nebulizer Systems Companies – Pipeline Products by Stage of Development 15

Nebulizer Systems – Pipeline Products by Stage of Development 17

Ablynx NV Pipeline Products & Ongoing Clinical Trials Overview 18

Customised Infant Inhalation Device – Product Status 18

Customised Infant Inhalation Device – Product Description 18

Acu-Flow Ltd Pipeline Products & Ongoing Clinical Trials Overview 19

Next Generation Nebulizer – Product Status 19

Next Generation Nebulizer – Product Description 19

Aeon Research & Technology Pipeline Products & Ongoing Clinical Trials Overview 20

LYNX Nebulizer – Product Status 20

LYNX Nebulizer – Product Description 20

AFT Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview 21

NasoSURF – Product Status 21

NasoSURF – Product Description 21

AFT Pharmaceuticals Ltd – Ongoing Clinical Trials Overview 22

NasoSURF – Pharmacokinetics and Pharmacodynamics of Midazolam Administered Intranasally Using the Nasosurf Device to Healthy Volunteers 23

Bridgesource Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 24

Breath-Adaptive Nebulizer – Product Status 24

Breath-Adaptive Nebulizer – Product Description 24

Caddo Medical Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 25

Small-Volume Nebulizer – Product Status 25

Small-Volume Nebulizer – Product Description 25

Clyra Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 26

Nasal Nebulizer – Product Status 26

Nasal Nebulizer – Product Description 26

Creare LLC Pipeline Products & Ongoing Clinical Trials Overview 27

DDC-Based Nebulizer – Product Status 27

DDC-Based Nebulizer – Product Description 27

DesignWise Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 28

Self-Contained Nebulizer System – Product Status 28

Self-Contained Nebulizer System – Product Description 28

HCmed Innovations Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 29

AdheResp – Product Status 29

AdheResp – Product Description 29

LTT Bio-Pharma Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 30

LT-1002 – Product Status 30

LT-1002 – Product Description 30

Marquette University Pipeline Products & Ongoing Clinical Trials Overview 31

Human Powered Nebulizer – Product Status 31

Human Powered Nebulizer – Product Description 31

Misti Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 32

MyMisti – Product Status 32

MyMisti – Product Description 32

Monash University Pipeline Products & Ongoing Clinical Trials Overview 33

High-Flow Nebuliser – Product Status 33

High-Flow Nebuliser – Product Description 33

Nebuliser – Product Status 34

Nebuliser – Product Description 34

New Air, Inc. Pipeline Products & Ongoing Clinical Trials Overview 35

WiseAir – Product Status 35

WiseAir – Product Description 35

Nob Hill Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 36

DryNeb – Product Status 36

DryNeb – Product Description 36

PARI GmbH Pipeline Products & Ongoing Clinical Trials Overview 37

Vibrating Mesh Nebulizer For RespiraClear – Product Status 37

Vibrating Mesh Nebulizer For RespiraClear – Product Description 37

Parion Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 38

tPAD Device – Product Status 38

tPAD Device – Product Description 38

Pharmosa Biopharm Inc Pipeline Products & Ongoing Clinical Trials Overview 39

L606 Inhalation System – Product Status 39

L606 Inhalation System – Product Description 40

L608 Inhalation System – Product Status 40

L608 Inhalation System – Product Description 40

Pharmosa Biopharm Inc – Ongoing Clinical Trials Overview 41

L606 Inhalation System – A Phase 3, 2-Part, Open-Label Study to Evaluate the Safety and Tolerability of Liposomal Treprostinil Inhalation Suspension (L606) in Subjects With Pulmonary Arterial Hypertension or Pulmonary Hypertension Associated With Interstitial Lung Disease 42

Qnovia Inc Pipeline Products & Ongoing Clinical Trials Overview 43

RespiRx – Nicotine Replacement Therapy (NRT) – Product Status 43

RespiRx – Nicotine Replacement Therapy (NRT) – Product Description 43

RMIT University Pipeline Products & Ongoing Clinical Trials Overview 44

Respite Nebulizer – Product Status 44

Respite Nebulizer – Product Description 44

UAS Nebulizer – Product Status 45

UAS Nebulizer – Product Description 45

Stirling Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview 46

High Density Aerosol Drug Delivery Device – Product Status 46

High Density Aerosol Drug Delivery Device – Product Description 46

Suzhou Wulian Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 47

Nebulization Drug Delivery Device – Product Status 47

Nebulization Drug Delivery Device – Product Description 47

Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview 48

Turbomist – Product Status 48

Turbomist – Product Description 48

Tianchen (Tianjin) Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 49

Portable Ultrasonic Nebulizer – Product Status 49

Portable Ultrasonic Nebulizer – Product Description 49

University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 50

Nebulizer – Product Status 50

Nebulizer – Product Description 50

University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 51

Pulse Drug Nebulization System – Product Status 51

Pulse Drug Nebulization System – Product Description 51

Vectura Group Plc Pipeline Products & Ongoing Clinical Trials Overview 52

VR475 Combination Device – Product Status 52

VR475 Combination Device – Product Description 52

VR647 – Product Status 53

VR647 – Product Description 53

Vectura Group Plc – Ongoing Clinical Trials Overview 54

VR647 – Phase III Study of VR-647 55

Verona Pharma Plc Pipeline Products & Ongoing Clinical Trials Overview 56

Ensifentrine + LAMA Nebulizer – Product Status 56

Ensifentrine + LAMA Nebulizer – Product Description 56

RPL554 Nebulizer – Product Status 57

RPL554 Nebulizer – Product Description 57

Vincent Medical Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview 58

Home Use Ultrasonic Nebulizer – Product Status 58

Home Use Ultrasonic Nebulizer – Product Description 58

Wellfully Ltd Pipeline Products & Ongoing Clinical Trials Overview 59

Nebulizer – Product Status 59

Nebulizer – Product Description 59

Wellinks Inc Pipeline Products & Ongoing Clinical Trials Overview 60

Bluetooth Enabled Flyp Nebulizer – Product Status 60

Bluetooth Enabled Flyp Nebulizer – Product Description 60

Wellinks Inc – Ongoing Clinical Trials Overview 61

Bluetooth Enabled Flyp Nebulizer – POWER: Prospective, Observational Study of Wellinks Effect on COPD Hospital Readmissions 62

Glossary 69

Figures

Nebulizer Systems – Pipeline Products by Stage of Development 10

Nebulizer Systems – Pipeline Products by Territory 11

Nebulizer Systems – Pipeline Products by Regulatory Path 12

Nebulizer Systems – Pipeline Products by Estimated Approval Date 13

Nebulizer Systems – Ongoing Clinical Trials 14

Frequently asked questions

Nebulizer Systems Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

Most Popular
$8,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Nebulizer Systems Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Nebulizer Systems reports
Medical Devices
New
Global M&A Deals in H1 2026 - Top Themes by…
$495 | August 2026
Medical Devices
New
Medical Devices M&A Deals H1 2026 - Top Themes: Strategic…
$495 | July 2026
Medical Devices
New
AI-designed Materials: Market Trends and Innovations
$995 | July 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Nebulizer Systems Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Nebulizer Systems Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more